H-group (homology)
140.1 Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases
Ligands and drugs
4,544
Member domains
201
with ligand contacts (≤ 4 Å)
4.4% of members
154
with DrugDomain annotations
3.4% of members
96
with a DrugBank compound
2.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 140.1 belongs to X-group 140 Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases, which binds 6.8 ligand superclasses per 20 proteins, narrower than 63% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00134 | MET | Methionine | 28 |
| DB00410 | MRC | Mupirocin | 6 |
| DB00171 | ATP | ATP | 5 |
| DB02916 | LMS | [(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate | 5 |
| DB02831 | 2HP | Dihydrogenphosphate | 4 |
| DB02229 | MSP | 5'-O-[(L-methionyl)-sulphamoyl]adenosine | 3 |
| DB00151 | — | Cysteine | 2 |
| DB00167 | — | Isoleucine | 2 |
| DB02684 | 5CA | 5'-O-(L-Cysteinylsulfamoyl)adenosine | 2 |
| DB00125 | ARG | Arginine | 1 |
| DB00131 | AMP | Adenosine phosphate | 1 |
| DB00149 | — | Leucine | 1 |
| DB00161 | — | Valine | 1 |
| DB01755 | ILA | N-[Isoleucinyl]-N'-[adenosyl]-diaminosufone | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| LSS | 5'-O-(L-leucylsulfamoyl)adenosine | 19 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 11 |
| ILA | N-[ISOLEUCINYL]-N'-[ADENOSYL]-DIAMINOSUFONE | 8 |
| LMS | [(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDRO-2-FURANYL]METHYL SULFAMATE | 8 |
| MRC | MUPIROCIN | 8 |
| GSU | O5'-(L-GLUTAMYL-SULFAMOYL)-ADENOSINE | 6 |
| MGmetal | MAGNESIUM ION | 6 |
| AMP | ADENOSINE MONOPHOSPHATE | 5 |
| 2HP | DIHYDROGENPHOSPHATE ION | 4 |
| USB | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] (2~{S})-2-azanyl-4-methyl-pentanoate | 4 |
| VAA | N-[VALINYL]-N'-[ADENOSYL]-DIAMINOSUFONE | 4 |
| CL | CHLORIDE ION | 3 |
| MSP | 5'-O-[(L-METHIONYL)-SULPHAMOYL]ADENOSINE | 3 |
| TAR | D(-)-TARTARIC ACID | 3 |
| 5CA | 5'-O-(N-(L-CYSTEINYL)-SULFAMOYL)ADENOSINE | 2 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 2 |
| 84T | [(2S,4S,5R)-5-(6-aminopurin-9-yl)-4-oxidanyl-oxolan-2-yl]methoxy-N-[(2S,3R)-4-methyl-2,3-bis(oxidanyl)pentanoyl]phosphonamidic acid | 2 |
| A1CYZ | 5'-O-[(R)-{[(2R)-2-amino-3-sulfanylpropanoyl]oxy}(hydroxy)phosphoryl]adenosine | 2 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 2 |
| GV6 | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] (2S,3S)-2-azanyl-3-methyl-pentanoate | 2 |